PT96231A - Metodo para a producao de proteinas bcrf1 uteis com inibidores do interferao gama e metodo para a sua utilizacao - Google Patents

Metodo para a producao de proteinas bcrf1 uteis com inibidores do interferao gama e metodo para a sua utilizacao

Info

Publication number
PT96231A
PT96231A PT96231A PT9623190A PT96231A PT 96231 A PT96231 A PT 96231A PT 96231 A PT96231 A PT 96231A PT 9623190 A PT9623190 A PT 9623190A PT 96231 A PT96231 A PT 96231A
Authority
PT
Portugal
Prior art keywords
useful
production
inhibitors
utilization
bcrf1
Prior art date
Application number
PT96231A
Other languages
English (en)
Other versions
PT96231B (pt
Inventor
Kevin W Moore
Robert A Kastlein
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of PT96231A publication Critical patent/PT96231A/pt
Publication of PT96231B publication Critical patent/PT96231B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/141—Interleukin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT96231A 1989-12-20 1990-12-18 Metodo para a producao de proteinas bcrf1 uteis com inibidores do interferao gama e metodo para a sua utilizacao PT96231B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45393189A 1989-12-20 1989-12-20

Publications (2)

Publication Number Publication Date
PT96231A true PT96231A (pt) 1991-09-30
PT96231B PT96231B (pt) 1998-09-30

Family

ID=23802631

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96231A PT96231B (pt) 1989-12-20 1990-12-18 Metodo para a producao de proteinas bcrf1 uteis com inibidores do interferao gama e metodo para a sua utilizacao

Country Status (27)

Country Link
US (2) US5627155A (pt)
EP (1) EP0506836B1 (pt)
JP (1) JP2648236B2 (pt)
KR (1) KR960015199B1 (pt)
CN (1) CN1057012C (pt)
AT (1) ATE112317T1 (pt)
AU (1) AU7899694A (pt)
CA (1) CA2071907C (pt)
CZ (1) CZ283049B6 (pt)
DE (1) DE69013011T2 (pt)
DK (1) DK0506836T3 (pt)
ES (1) ES2064082T3 (pt)
FI (1) FI104883B (pt)
HK (1) HK185396A (pt)
HU (1) HU215909B (pt)
IE (1) IE72203B1 (pt)
IL (1) IL96715A0 (pt)
MX (1) MX9203409A (pt)
MY (1) MY107449A (pt)
NO (1) NO305703B1 (pt)
NZ (1) NZ236512A (pt)
OA (1) OA09703A (pt)
PH (1) PH31669A (pt)
PT (1) PT96231B (pt)
SK (1) SK635190A3 (pt)
WO (1) WO1991009127A1 (pt)
ZA (1) ZA9010188B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
JPH04505019A (ja) * 1989-10-23 1992-09-03 シェリング・コーポレーション ガンマインターフェロンのポリペプチド性阻害剤
ATE116550T1 (de) * 1991-01-16 1995-01-15 Schering Corp Behandlung von neoplastischen krankenheiten mit interleukin-10.
US6106823A (en) * 1991-01-16 2000-08-22 Schering Corporation Treatment of neoplastic disease with interleukin-10
US5833976A (en) * 1991-08-06 1998-11-10 Schering Corporation Use of interleukin-10 (IL-10) to treat endotoxin- or superantigen-induced toxicity
EP0600970B1 (en) * 1991-08-06 1999-12-08 Schering Corporation Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity
DE69332197T2 (de) * 1992-03-13 2003-04-17 Organon Teknika B.V., Boxtel Epstein-Barr-Virus verwandte Peptide und Nukleinsäuresegmenten
US6008327A (en) 1992-03-13 1999-12-28 Akzo Nobel, N.V. Peptides and nucleic acid sequences related to the Epstein Barr virus
WO1993018783A1 (en) * 1992-03-20 1993-09-30 Schering Corporation Use of interleukin-10 to induce the production of interleukin-1 receptor antagonist
EP0726315B1 (en) * 1993-07-23 2001-10-17 Hans Prof. Dr. Wolf Epstein-Barr virus DNA sequences encoding a diagnostically relevant virus capsid antigen, expression clones derived through polymerase chain reaction and the use of this recombinant antigen in diagnostic tests
US5616724A (en) * 1996-02-21 1997-04-01 Cephalon, Inc. Fused pyrrolo[2,3-c]carbazole-6-ones
WO1999008110A1 (en) * 1997-08-08 1999-02-18 Newbiotics, Inc. Methods and compositions for overcoming resistance to biologic and chemotherapy
SG11201402490XA (en) 2011-11-23 2014-06-27 Amgen Inc Methods of treatment using an antibody against interferon gamma
WO2022016509A1 (zh) * 2020-07-24 2022-01-27 阎忠扬 一种用以筛选药物的方法，以及该药物用于治疗牛皮癣的用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0173254B1 (en) * 1984-08-23 1991-07-24 Hans Joachim Wolf Dna sequences of the ebv genome, recombinant dna molecules, processes for producing ebv-related antigens, diagnostic compositions and pharmaceutical compositions containing said antigens
US5256768A (en) * 1985-12-13 1993-10-26 The Johns Hopkins University Expression of antigenic Epstein-Barr virus polypeptides in bacteria and their use in diagnostics

Also Published As

Publication number Publication date
HU9202075D0 (en) 1992-10-28
CZ283049B6 (cs) 1997-12-17
SK279830B6 (sk) 1999-04-13
PH31669A (en) 1999-01-18
DE69013011D1 (de) 1994-11-03
FI922770A0 (fi) 1992-06-16
ES2064082T3 (es) 1995-01-16
NO305703B1 (no) 1999-07-12
CN1052608A (zh) 1991-07-03
IE904588A1 (en) 1991-07-03
MX9203409A (es) 1992-07-01
AU7063691A (en) 1991-07-18
DK0506836T3 (da) 1994-11-28
CA2071907A1 (en) 1991-06-21
HK185396A (en) 1996-10-11
ATE112317T1 (de) 1994-10-15
KR960015199B1 (ko) 1996-11-01
FI922770L (fi) 1992-06-16
NO922456D0 (no) 1992-06-19
CZ635190A3 (en) 1997-09-17
US5627155A (en) 1997-05-06
JPH05503846A (ja) 1993-06-24
EP0506836A1 (en) 1992-10-07
IL96715A0 (en) 1991-09-16
NZ236512A (en) 1997-07-27
EP0506836B1 (en) 1994-09-28
HU215909B (hu) 1999-03-29
CA2071907C (en) 2000-08-08
HUT65369A (en) 1994-05-02
SK635190A3 (en) 1999-04-13
US5736390A (en) 1998-04-07
PT96231B (pt) 1998-09-30
OA09703A (en) 1993-08-30
AU7899694A (en) 1995-02-09
ZA9010188B (en) 1991-08-28
CN1057012C (zh) 2000-10-04
WO1991009127A1 (en) 1991-06-27
IE72203B1 (en) 1997-04-09
DE69013011T2 (de) 1995-02-23
AU652732B2 (en) 1994-09-08
JP2648236B2 (ja) 1997-08-27
NO922456L (no) 1992-06-19
FI104883B (fi) 2000-04-28
MY107449A (en) 1995-12-31

Similar Documents

Publication Publication Date Title
PT96231A (pt) Metodo para a producao de proteinas bcrf1 uteis com inibidores do interferao gama e metodo para a sua utilizacao
ATE126441T1 (de) Pentigetide zur behandlung von nicht-ige- vermittelten entzündlichen erkrankungen.
ES8602768A1 (es) Un procedimiento para la preparacion de nuevas n-(heterociclil biciclo)-4-piperidinaminas.
RU94036748A (ru) Церамиды, способ их получения, композиция на их основе и способ гидратирующей обработки кожи или волос
DE3855525D1 (de) Verwendung eines Protein gebundenen Polysaccharid Zur Herstellung eines Arzneimittels für die Behandlung von AIDS.
BR8707042A (pt) Implante,processo para sua producao e modificacoes de tal processo
ATE76294T1 (de) Galanthamin oder dessen analoge zur behandlung der alzheimerschen krankheit.
DE3884973D1 (de) Verfahren zur Herstellung von Avermectine-B und die verwendeten Kulturen.
ES2061823T3 (es) Nueva proteina h que es capaz de fijarse a igg, gen que codifica dicha proteina h, y un procedimiento para producir dicha proteina h.
DE69130679D1 (de) Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
DE69007486D1 (de) Verwendung von calciumantagonisten für die behandlung von narben.
ES2066096T3 (es) 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
DE69626816D1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
MX9202366A (es) Nuevas 2-amino-5-ciano-1,4-di hidro piridinas y procedimiento para su fabricacion.
ES2076141T3 (es) 5-aril-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
IE870577L (en) Topical amide preparation
BE867682A (fr) Procede de preparation de cheveu artificiel implantable, et cheveux artificiels ainsi obtenus
DE69331231D1 (de) Ein neuartiges, antineoplastisches cytokin
ES8801624A1 (es) Procedimiento para preparar disulfuros heterociclicos
DE69636814D1 (de) Verwendung des menschlichen choriongonadotropins in der behandlung von kaposi's-sarcoma
DE3773393D1 (de) Mikrokompresse oder haemorrhoidal-verband sowie dessen herstellungsverfahren.
IT8921616A0 (it) Procedimento per la produzione di agenti di conciatura sintetici e per conciare cuoio.
ES2109970T3 (es) Dietanolato del etoposido 4'-fosfato cristalino.
BR8301078A (pt) Processo de fabricacao de couro artificial e produto obtido

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910506

FG3A Patent granted, date of granting

Effective date: 19980626

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20031231